BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr | ₹0.00 Cr |
What is the latest Cash Flow from Operating Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-35 Cr |
| Mar2024 | ₹4.87 Cr |
| Mar2023 | ₹6.08 Cr |
| Mar2022 | ₹34 Cr |
| Mar2021 | ₹0.00 Cr |
How is Cash Flow from Operating Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-35 Cr | Negative | |
| Mar2024 | ₹4.87 Cr | -19.90 | |
| Mar2023 | ₹6.08 Cr | -82.21 | |
| Mar2022 | ₹34 Cr | 1,138,066.67 | |
| Mar2021 | ₹0.00 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹138.6 Cr | 0.8% | -10.4% | -68% | Stock Analytics | |
| ADANI ENTERPRISES | ₹269,847.0 Cr | -3.2% | -7.8% | -12.5% | Stock Analytics | |
| REDINGTON | ₹20,287.1 Cr | -1.5% | -5.6% | 26.5% | Stock Analytics | |
| MMTC | ₹9,738.0 Cr | -5.8% | 14.9% | -7.7% | Stock Analytics | |
| HONASA CONSUMER | ₹8,978.6 Cr | -3.6% | 3.5% | 10.7% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,447.9 Cr | -5.3% | -24.6% | 6.8% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 0.8% |
-10.4% |
-68% |
| SENSEX | -1.3% |
-3.1% |
6.8% |
You may also like the below Video Courses